to the normal generation of the wide array of distinct cell types that comprise the mature vertebrate CNS. Here, we demonstrate a critical role for Cip/Kip class cyclin-kinase inhibitory (CKI) proteins in regulating this process during neurogenesis in the embryonic spinal cord. Using immunohistochemistry, we show that all three identified Cip/Kip CKI proteins are expressed in both distinct and overlapping populations of nascent and post-mitotic neurons during early neurogenesis, with p27
numbers of progenitors available to generate subsequent neuronal, and glial, types. Although the core cellular mechanisms regulating progenitor cell cycle exit and differentiation in the CNS are similar to other developing organ systems, it is unclear whether similar factors play equivalent roles in all tissues or whether context-dependent differences exist in their function.
The current study addresses these issues using the vertebrate spinal cord as a model system. In this structure, distinct classes of neurons are generated during neurogenesis in discrete domains along the dorsoventral (DV) axis, and derive from similarly organized progenitor domains (Jessell, 2000) . In the spinal cord, the production of post-mitotic neurons from neuronal progenitors (neurogenesis) begins shortly after the fonnation of the neural tube, and is largely complete by mid-gestation. As in most other regions of the developing CNS, proliferating cells in the spinal cord reside in the ventricular zone (VZ) and undergo interkinetic nuclear migration during progression through the cell cycle. During this process, cell nuclei translocate between the lumenal and pial sides of the VZ, with the position of the nucleus correlating with phases of the cell cycle: nuclei close to the lumen medially are in M-phase, those located laterally towards the pial surface are in S-phase, and those that are in transit are in G I or G2.
Studies in cell culture have shown that the decision to continue or withdraw at each cycle is controlled by mitogen availability and is mediated by D-type cyclins at a point late in G I phase, temled R (for" restriction point; Sherr and Roberts. 1999) . Many signals are thought to exert their control over the cell cycle at R. For example, various mitogens and integrin-mediated ECM signals stimulate cell cycle progression, while factors such as TGF-r'> can induce cell cycle withdrawal (Assoian and Schwartz, 2001) . Completion of a cell cycle (passage through M-phase) after crossing R is independent of further inputs (Sherr and Roberts, 1999) . In the spinal cord, nascent neurons that withdraw from the cell cycle enter a GO state and migrate out of the VZ into the mantle zone (MZ), an area of accumulating neurons that becomes the adult gray matter. This transition takes place when their nuclei are positioned laterally in the VZ during late G I phase.
A number of factors have been identified whose expression is either initiated in or confined to cells near the lateral margins of the VZ during neurogenesis, making them good candidates for regulating the transition of progenitor cells into neurons. Among these are p27 Kip1 and 57 Kip2 ,  two of the three members of the vertebrate Cip/Kip family of cyclin-dependentkinase inhibitor (CKI) proteins (Sherr and Roberts, 1999; Zhang, 1999) . The expression and function of the third member, p21 Cipl, has not been characterized extensively in the developing CNS.
Several lines of evidence indicate that Cip/Kip factors play an important role in many tissues to prevent cell cycle progression at the G tiS restriction point (R) via control of Rb phosphorylation, a factor that is a critical regulator of the E2F factors that control the transcription of S-phase DNA synthesis genes (Macleod, 1999; Hamel et aI., 1992) . First, the expression of these factors is largely confined to post-mitotic cells (Nagahama et aI., 2001; Westbury et aI., 2001 KiP2 mutants exhibit various proliferative defects consistent with their requirement in arresting mitosis in various organs of the body (Fero et aI., 1996; Kiyokawa et aI., 1996; Nakayama et aI., 1996; Van et aI., 1997; Zhang et aI., 1998) . Third, gain-offunction experiments have shown that these proteins are capable of driving proliferating cells out of the cell cycle (Sherr and Roberts, 1999; Dyer and Cepko, 2000, 200 I) . In the mammalian CNS, the role of p27 and p57 has been studied in retinal histogenesis. In the absence of each of these CKls, additional rounds of cell division are seen, along with changes in the proportions of retinal sub-types depending on which Cip/Kip CKI is lost (Dyer and Cepko, 2000, 2001) . These studies are consistent with a model where individual Cip/Kip CKls are required for cell cycle exit in unique sub-populations of cells, and suggest that different populations employ distinct mechanisms to control cell cycle exit. However, a number of questions remain unanswered.
First, it is unclear whether differences in the requirement for these factors represent functional differences between the proteins, or are related to specific patterns of expression in different tissues. Although previous studies have shown that there is some functional redundaricy among and between the two major families of CKI proteins (Cip/Kip and INK4), it has not yet been determined whether all CKI activity is required for cell cycle exit. Second, prior studies have not established whether the requirement for Cip/Kip CKIs is cell-autonomous.
Because loss of cell cycle control in vivo often leads to apoptosis and non-cell-autonomous tissue defects, this question bears not only on understanding Cip/ Kip CKI function but also on the broader mechanisms that balance neuronal proliferation with differentiation. Finally, although transfection studies in cell culture have demonstrated the ability ofCip/Kip CKI factors to block cell cycle progression via inhibition of G 1 cyclin (cyclin D) activities, it is unclear whether similar mechanisms are responsible for this effect in vivo (Dyer and Cepko, 2000) .
In this study, we set out to address these issues using a combination of in vivo approaches in the embryonic mouse and chick spinal cord. We find that all three identified Cip/Kip proteins are expressed in subsets of neurons in the spinal cord during neurogenesis, with both p21 and p57 being expressed transiently in the nuclei of distinct sub-classes of nascent intemeurons exiting the ventricular zone, while p27 expression is initiated and maintained in the nuclei of post-mitotic neurons in the mantle zone. Thus, most or all post-mitotic neurons within the mouse spinal cord express at least one, and sometimes two, Cip/Kip CKI proteins at early neurogenic stages. In contrast, some INK4-family CKIs are only expressed in neuronal progenitor cells at these stages and therefore are not likely to function in controlling cell cycle exit or differentiation decisions (Zindy et aI., 1997a,b) . To determine the requirement for Cip/Kip CKI proteins in spinal cord neurogenesis, we examined the development of single and compound mutant mice. We find that loss of p57 results in the excess production 'of most, but not all, classes of early-generated intemeurons. In contrast, loss of p27 has no consequences on early neurogenesis. Utilizing a method to genetically mark cells that express p57, we find that in the absence of this factor, many intemeurons re-enter the cell cycle for at least one additional round of cell division before ultimately differentiating. We also demonstrate the requirement ofthe N-tenninal CKI domain ofp57 in functioning downstream of Cyclin D I to arrest proliferation in progenitors. Finally, our data shows that neuronal differentiation can proceed in the spinal cord, albeit abnormally, in the absence of all Cip/Kip CKI proteins. Our studies support a model whereby cell cycle exit involves multiple steps, with exit being triggered upstream of Cip/Kip CKls, which function primarily to control the specific timing and number of spinal intemeurons by opposing latent Cyclin D I and other residual cell cycle promoting activities in progenitors targeted for differentiation.
p27 ':i,d (Kiyokawa et aI., 1996) and p5r;,'1 knockout micc (Zhang et aI., 1997) werc maintained on C57BL/6 and CD I backgrounds. Double mutant mice were generated by crossing heterozygous adult mice. Genotypes were determined by PCR as described (Zhang et aI., 1998) . The p57 allele is imprinted in mammals (Zhang et al.. 1998) , such that interbreeding of targeted hcterozygous parents will give rise to both genetic (2 targeted alleles) and imprinted (I targeted and I paternally imprinted allele) mutant offspring. However, to avoid potential variability in the phenotypes of these two populations, only genetically identified homozygote knockout embryos were analyzed in this study. To generate genetic p5T
1 -mutants expressing a LacZ reporter in p57+ cells, heterozygous male p5T 1 -mice were first crossed with transgenic mice generated from a modified 85 kb BAC clone engineered to express LacZ in place of p57 (John et aI., 200 I), which were then intererossed to generate litters containing both p5T 1 - null homo zygotes and LacZ transgene allele/s. Transgenics were identified by PCR as described (Brinkmeier et aI., 1998) .
To specifically label neural progenitors in S-phase, a single injection of BrdU (5 mg/ml in 0.9% NaCI) was given to pregnant female mice i.p. (50 pg/g) at various time-points (2,4, 6, 8, 10 and 12 h) prior to sacrificing. Because BrdU is rapidly cleared from the maternal circulation, this protocol provides a means to "pulse-label" cells that arc in S-phase only around the time of injection. During early neurogenic stages, cell cycle length for proliferating neural tube progenitors in rodent embryos is about 8-10 h, with S-phase comprising approximatcly 2-4 h of this (Allman and Bayer, 1984) . Thus, short intervals between BrdU injection and sacrifice (~4 h) will predominantly label cells that arc actively dividing, while longer pulses (~8-1 0 h) arc required to label cells that have withdrawn from the cell cycle. For chick embryos, a one-time application of BrdU was made by pipetting 0.2 ml of a 5 mg/ml solution onto embryos after windowing. Eggs were then scaled and returned to the incubator for 30 min before collecting. Because BrdU remains present throughout this period in eggs, this protocol only labels cells in S-phase.
Full-length cDNAs and deletion constructs were sub-cloned into the pCIG vector that also encodes nuclear GFP under the control of an IRES element (Megason and McMahon, 2(02) . The p57 CKI domain (aa 1-92 of the 335 aa full-length protein) and CKI deleted (toCKI) form (aa 93-335) were generated by PCR and cloned in-frame into pCS2 + MT. For eo-eleetroporations, plasmid concentrations were adjusted to equal single-construct transfeetions.
Constructs were injected into the lumen of the neural tube of stage 12-14 chick embryos (Hamburger and Hamilton, 1951) and electroporated as described (Lei et aI., 2004) . Embryos were collected 24-48 h after transfeetion at stages 19-24.
In situ hybridization and immunohistochemistry were performed on 12-14 pm eryoseetions as described (Matise et aI., 1998) . Antibodies used were mouse anti-p21 and p27 (BD Pharmingen), BrdU (Sigma), eyclin D I (Upstate Biotechnology), [sll, Lhx 1/2, Lhx3, Pax6, Pax7, e-myc (Developmental Studies Hybridoma Bank), Ngn2 (gift from L. Lo), NeuN (Chemieon), TuJI (Co vance), Neurofilament (Sigma); rabbit anti-p57 (Santa Cruz), Pax2 (Zymed), En-I (gift from A. Joyner), phosphorylated Histone-H3 (Upstate Biotechnology), easpasc-3 (Idun Phannaecutieals), Chx I0 (gift from K. Sharma); goat anti-mouse p57 (Santa Cruz); guinea-pig anti-Prox- [ (Misra and Matise, unpublished data) , Lmx Iband Evx I (gift from T. Jessell). RNA in situ probes were mouse p57 (gift from M. Lee), and ehiekp57 ESTs (accession numbers BM489375, BM491273).
For quantification, more than 5 embryos for each group were examined and at least five sections were counted per marker. In Figs. 6 and 7, GFP+ transfeeted cells expressing BrdU were compared between control and experimental vectors, and a ratio was derived for each experimental group as indicated. Statistical significance was determined by paired Hest. [n bar charts, error bar~SEM for all figures.
Cip/Kip family CKls display distinct spatial and temporal patterns of expression in differentiating neurons in the embryonic mouse spinal cord
To address the role of Cip/Kip class cyclin kinase inhibitors (CKIs) in controlling neuronal differentiation in the developing spinal cord, we used immunohistochemistry to localize p21 Cip I, p27
Kipl and p57 Kip2 proteins during neurogenesis between embryonic day (E) 9.5-13.5 ( Fig. 1 and Fig. SI ). In this structure, progenitor cells residing in the ventricular zone (VZ) exit the cell cycle and migrate laterally to settle in the mantle zone (MZ) to differentiate. During early neurogenesis, functionally distinct neuronal types are generated in specific and discrete domains along the dorsoventral (DV) axis, and can be identified by a unique homeodomain (HD) protein expression profile (Jessell, 2000) . All three CKI factors were expressed in overlapping but distinct groups of cells located at the lateral border of the VZ. p21 Cip I expression was detected medial to cells expressing ChxlO, which marks ventral interneurons within the V2 domain dorsal to motoneurons (MNs) (Fig. IA) . In contrast, p57 was expressed more broadly along the DVaxis in two stripes of cells at the lateral margin of the VZ/proximal part of the MZ, but was excluded specifically from the ventral V2 and MN domains (Fig. I B) . A similar pattern of expression was seen for p57 mRNA in both mouse and chicken spinal cords at equivalent stages (Figs. I D, E). p27 Kip I had the broadest pattern ofthe three Cip/Kip CKIs, being expressed in nearly every cell within the MZ but not in progenitors ( Fig. 1C ; see also Novitch et al., 2001 for chick expression). As a result, p27 is co-expressed with both p21 and p57 in the lateral aspects of their expression domains (Figs. I F and 2E; data not shown). Thus, most or all post-mitotic neurons within the mouse spinal cord express at least one, and sometimes two, Cip/Kip CKI proteins at early neurogenic stages (Fig. IF) .
To begin to address the role of Cip/Kip CKIs in neural differentiation, we focused on p57, which shows widespread but transient expression in most early primary interneuron classes. BrdU labeling was used to determine the timing of p57 expression relative to S-phase of the cell cycle (see Materials and methods for details of the labeling protocol). Single injections of BrdU given to pregnant females 2, 4 and 6 h prior to sacrifice labeled only a small number ofp57+ cells in embryos, while at 8 h the number increased slightly above this ( Fig. 2A) . Coexpression increased sharply (5-fold) 12 h after BrdU administration ( Fig. 2A ). This finding suggests that strong p57 expression occurs at the terminal G 1 phase after the final mitosis. To further examine this, we compared p57 expression to other factors that mark specific progenitor and neural populations, p57+ cells are largely located lateral to Pax6+ and Ngn2+ progenitor cells in the VZ, while a small number co-express both factors in the region of overlap between the two expression domains (Figs, 2B, C), The majority of medially positioned p57+ cells co-expressed the G I phase marker Cyclin D I (Fig,  2D) , while laterally positioned p57 cells co-expressed mature neuronal markers p27, TuJ!, NeuN, and Neurofilament (NF) (Figs. 2E-G, K), as well as the Liml/2 and Pax2 HD protein, whose expression is initiated in post-mitotic cells ( Fig. 2I ; Matise and Joyner, 1997 ; data not shown). p57 was also coexpressed with Proxl (Fig. 2J) , a factor whose expression is similarly confined to newly born neurons exiting the VZ (Misra and Matise, unpublished data), Together, these data indicate that p57 expression marks nascent intemeurons as they undergo a transition from late G I to early GO phase after their terminal cell cycle in the lateral aspect of the VZ (Figs. 2H, L) .
To address the role of p57 in nascent intemeurons, we examined neurogenesis in targeted psr l -mutant mouse embryos (Zhang et aI., 1997) . Consistent with a role in inhibiting cell In contrast, in p5r l -mutants, many Pax2+/LimI/2+ cells coexpressed BrdU after a 2-h interval (Figs. 4B, D) .
Next, we examined BrdU incorporation in a transgenic mouse reporter line generated from a modified 85 kb mouse C57BLl6 BAC clone containing the p57 gene, which has been engineered using homologous recombination to express lacZ/~gal in place of p57 (John et al., 200 I) . It has been previously shown that lacZ expression from this transgenic reporter line is similar to endogenous p57 in the embryonic CNS (John et al., 200 I) . Closer examination of reporter expression in the spinal cord showed that r~-gal staining was detected in most, but not all, cells expressing endogenous p57 protein, while some cells expressed r~-gal but not p57, likely due to the greater perdurance of~-gal protein compared to p57, which is down-regulated rapidly as cells migrate into the MZ (Fig. 4E) . As with endogenous p57 protein, co-expression ofBrdU and r~-gal was detected only after BrdU injection/collection intervals exceeding 8-12 h, but not at 2 h ( Fig. 4F ; data not shown). Thus, the modified 85 kb p57 BAC transg~nic reporter mouse line faithfully recapitulates the timing and overall pattern of endogenous p57 expression in nascent spinal cord interneurons, although not all p57+ cells are marked.
The stability and perdurance of f)-gal protein provides a means to track the fate of cells that nomlally express p57 in a p5r lmutant background. To do this, we crossed the transgenic p57 BAC reporter line onto targeted p5r lmutants to generate p5rl-,p57BACI+ transgenic reporter/mutant embryos. LacZ reporter expression does not require p57 function in these embryos since f>,-galexpression is detected in a similar pattern in p5T
1 + and p5r lbackgrounds (Fig. 4G) . Consistent with our results above, we found a significant increase in !,he number of ['>-gal+ (p57+) cells that incorporated BrdU after a short interval (2 h) between injection and sacrifice in p5r l -; p57 BAC1 + mutants, compared to p57+1+;p57BACI+ embryos which show very little co-expression at this interval (39±6 vs. While our results above demonstrate that p57 is required for normal cell cycle exit in spinal cord intemeurons, it is apparent from our analysis that significant numbers of differentiated neurons are present in p5r lhomozygotes (cf. Figs. 3G, I ), suggesting that mutant cells are ultimately able to cease proliferation and differentiate even in the absence of p57. To address this issue, we counted the number of neurons within the MZ in mutant embryos using markers that identifY specific neuronal classes to allow comparison of cells that normally express p57 (e.g., En I+ V I cells) with those that do not (ChxlO+ V2 cells, MN) (Figs. I B, F) . Loss ofp57 resulted in a significant increase in the number of post-mitotic VI interneurons, while the number of V2 interneurons was not different from WT, consistent with the idea that loss of p57 results in cellautonomous changes in neuronal differentiation (Figs. 5A-D; data not shown). Notably, the time course for the generation of excess neurons paralleled neurogenesis, with the peak number of additional neurons being attained at EIl.5 and then declining thereafter but still remaining above WT levels (Fig. 5D ). At this J § C p57+f+; p57Tg~~. stage, more than 2-fold more post-mitotic neurons were found in mutant embryos compared to WT (Fig. 50) . In addition, a greater number of cells expressing activated caspase-3 were detected in p5T 1 -mutants compared to WT, indicating that some nascent neurons may undergo apoptosis in the absence of p57 (data not shown). Taking our results above showing re-entry into the cell cycle for p57-1 -mutant cells, our findings are consistent with the idea that, in the absence of p57 function, neuronal progenitors targeted for differentiation undergo at least I additional round of cell division before ultimately leaving the cell cycle to differentiate or, less frequently, undergo apoptosis.
P57.t-::57T
Our finding that spinal cord neuronal progenitors can exit the cell cycle even in the absence of p57 raises the possibility that other CKl factors might compensate for the loss ofp57 in mutant embryos. to address this, we examined neurogenesis in double
1 -mutants, since we found that p21 remains restricted to cells within the V2 domain in these embryos (Fig.   S I) . Thus, most cells in p2T 1 -,p5T 1 -embryos (with the exception of those in the V2 domain that continue to express p21) lack expression of all Cip/Kip family CKI proteins in the spinal cord. We studied neuronal proliferation and differentiation in these mutants spanning the neurogenic period, between ElO.5 and EI3.5. Notably, neurogenesis in p2T
1 -,p5T 
Overexpression of Cip/Kip CKl proteins fOl'Ces cell cycle arrest in neural progenitor cells
To address the function of p57 and other Cip/Kip proteins in controlling the timing of cell cycle exit in nascent interneuron progenitors, we used a gain-of-function approach in chick embryos. Using in ovo electroporation, we transfected each factor into neural progenitor cells using a bi-cistronic pCIG vector (Megason and McMahon, 2002 ) that also encodes GFP to allow the fate of transfected cells to be monitored. All three Cip/Kip family proteins were capable of arresting cell cycle progression in progenitors at 24 and 48 h post-transfection, as indicated by the total absence of BrdU incorporation in transfected cells and decreased incorporation of BrdU on the transfected side (Figs. 6B-E, H, and data not shown). For p57, the N-terminal CKI domain (Fig. 6A) was both sufficient and required for this activity (Figs. 6F-H) . These results are consistent with p57 functioning in a cell-autonomous manner to inhibit cyclin-dependent kinase activity in neural cells via the N-terminal cki domain.
To examine this further, we assayed whether p57 could interfere with the ability of cyclin D I to promote cell cycle progression. In agreement with similar results in other systems (Sherr and Roberts, 1999; Bartkova et aI., 1997) , forced overexpression of a cyclin D I cDNA elicited an increase in BrdU uptake in transfected cells compared to control (GFP-only) transfections (Figs. 7A, G) . Co-transfection of full-length p57 with cyclin D I blocked BrdU incorporation in co-transfected cells, indicating that it is capable of antagonizing cyclin D I celldivision-promoting activity (Fig. 7B) . To further assay the involvement of the p57 cki domain, we co-transfected either the p57 cki domain alone with cyclin D I, or a construct containing a deletion of the cki domain (see Figs. GA, F, G) . Only the p57 cki domain, but not a C-terrninal construct that lacked the cki domain, was capable of blocking cyclin DJ-stimulated increase in BrdU incorporation (Figs. 7C-G) . These findings are consistent with the idea that p57 functions to arrest cell cycle progression at G I by antagonizing cyclin D I function in neural progenitor cells via the N-terminal cki domain. Co-transfeetion of full-length p57 with cyeD I blocks this effect and prevents BrdU incorporation in transfeeted cells. Co-exprcssion was detcnnincd by using a mousc-specifie p57 antisera that docs not cross-react with endogenous chick p57 (not shown); GFP cxpression marks CycDI transfected cells in thesc panels. (C-F) The p57 CKI domain is sufficient and required to block cycDIstimulated increase in BrdU incorporation. For thesc experimcnts, myc-tagged p57 truncation/deletion constructs were used in eo-transfection experiments, and staining with anti-Myc antibodies shows a high degree ofeo-exprcssion ofthcse with CycD I (GFP) (C, E). The p57 cki domain alone, but not a construct encoding the remainder ofthc p57 protein abscnt the CKI domain, could block the activity ofCyeD I. Taking together, our data suggests that the p57 Cip/Kip CKI is dispensable for neuronal cell cycle exit but is required for timely withdrawal, suggesting that the initial trigger for termination of the cell cycle occurs in progenitors upstream of p57. To test this idea, we mis-expressed Ngn2, a neurogenic factor that has been previously shown to drive neuronal progenitors toward differentiation (Lo et aI., 2002) and is coexpressed with p57 in many nascent intemeurons (Fig. 2C) . Indeed, over-expression ofNgn2 in chick neural progenitor cells resulted in the up-regulation of neuronal markers as well as precocious activation of p57 expression (Figs. 7H-J ). In contrast, Ngn2 expression was not activated by mis-expression of p57 (data not shown), consistent with a genetic heirarchy placing bHLH neurogenic factors upstream of the p57 Cip/Kip protein in enacting cell cycle withdrawal in neural progenitors in the spinal cord (Fig. 7K ).
Control over cell cycle exit is fundamental to the normal generation of the wide array of distinct cell types that comprise the mature vertebrate CNS. Here, we demonstrate a central role for the p57
Kip2 cyclin-kinase inhibitory (CKI) protein in regulating this process in a subset of intemeurons during neurogenesis in the embryonic spinal cord. We provide direct genetic evidence supporting a cell-autonomous requirement for p57 in controlling cell cycle exit for spinal cord intemeurons.
In homozygous p5 7-1 -mouse mutants, many intemeurons targeted for cell cycle withdrawal and differentiation undergo additional mitotic cycles outside of the VZ. Because Chx I0+ V2 interneurons, which do not nonnally express p57, are generated in nonnal numbers, these results demonstrate that p57 activity is required to establish the appropriate proportions of interneuron sub-classes in the developing spinal cord. Gain-of-function studies in chick embryos show that forced expression of p57 in proliferating progenitor cells blocks cell cycle progression by interfering with the cell cycle promoting activities of Cyclin D 1.
Our analysis of compound p27;p57 homozygous mutant mice which lack Cip/Kip protein expression in most spinal interneurons provides evidence that Cip/Kip family CKls are not required for neuronal cell cycle exit during neurogenesis, but rather function to control the precise timing, and hence overall number, of the majority ofinterneurons generated during spinal cord development. Our studies support a multi-step model for neuronal progenitor cell cycle withdrawal that involves p57 Kip2 in an important role opposing latent Cyclin D I and other residual cell cycle promoting activities in progenitors targeted for differentiation.
Compared with previous studies, our results demonstrate that the functional requirement for Cip/Kip CKI proteins during development varies in different tissue contexts.
p57 controls interneuron cell cycle exit via the N-terminal CKJ domain
The p57 protein contains several distinct conserved domains (see Fig. 6A ). One of these, the N-tenninal CKI domain, is highly conserved among all three Cip/Kip family CKI proteins (40-50% identity within 65 amino acids comprising this domain; Hashimoto et aI., 1998). Indeed, all three vertebrate Cip/Kip family CIU proteins share the property of being capable of arresting or delaying cell cycle progression when misexpressed in progenitors in various tissues (Zhang et aI., 1998; Cunningham et aI., 2002; Dyer and Cepko, 2000; Tarui et aI., 2005) , as well as being required to prevent cell cycle re-entry (Zindy et aI., 1999; Dyer and Cepko, 2000, 2001 (Fig. S2) , indicative of increased Cdk activity, and consistent with the idea that reduced CKI function is responsible for this phenotype. To test the function of the CIU domain further, we used gain-of-function studies in chick embryos. All three Cip/ Kip CKI proteins were capable of preventing cell cycle progression in transfected spinal neuronal progenitors. Furthermore, we found that the N-tenninal CKI domain ofp57 was both sufficient and required for this activity. Consistent with the notion that cyclin 0 promotes cell cycle progression (Sherr, 1995) , overexpression of cyclin D I increased cell proliferation, and this activity that can be completely abrogated by cotransfection with p57 or its CKI domain. These results indicate that p57 functions downstream ofcyclin D, and are in agreement with results from earlier studies showing that p57 inhibits the activity of Cdk2 at the G liS checkpoint (Zhang et aI., 1997; Li et aI., 2004) .
Notably, we did not uncover evidence in our studies that the role of the Cip/Kip CKI proteins is critical for establishing distinct neuronal fates in spinal cord interneurons, unlike their role in the mammalian retina (Dyer and Cepko, 2000, 200 I) . Together, these results suggest that the process of retinal histogenesis is more critically linked to the precise timing of progenitor cell cycle exit than in the spinal cord, where neuronal classes may be distinguished primarily by spatial, rather than temporal, parameters.
Cip/Kip class CKJ proteins are dispensable for cell cycle exit during spinal cord neurogenesis p57 is one of three identified vertebrate members of the Cip/ Kip CKI class, the other two members being p21 and p27. Because these proteins have both common (cell cycle inhibitory) and unique functions, the observation that cell differentiation is not entirely inhibited in various tissues in single and double mutants for these factors has been reasonably ascribed to functional redundancy, but this possibility has been difficult to test genetically. To understand their unique and redundant functions in the developing neural tube, we began by examining their expression during neurogenesis. Virtually all differentiating neurons in the spinal cord express at least one Cip/Kip CKI during neurogenesis, and although there is some overlap, each has a unique spatial and temporal pattern (Fig. I) . Notably, our observation that p21, which shows the most restricted expression of the three Cip/Kip members in the spinal cord (to a single ventral interneuron domain), is not significantly altered in p27; p57 double mutants has afforded us an ideal opportunity to address this issue in the developing spinal cord.
We found that p2r l -,p5r ldouble mutants had a similar phenotype as single p5r lmutants. Nascent interneurons reentered cell cycle, but ultimately exited to differentiate in excess numbers. Furthennore, V2 interneurons, which express only p21 and p27, did not show any abnonnalities in cell cycle or differentiation (Fig. S2) . These results indicate that Cip/Kip class CKIs are dispensable for cell cycle exit during neurogenesis, and that p21 and p27 do not compensate for the loss ofp57 to block cell cycle re-entry in nascent interneurons. Interestingly, in lower vertebrates and invertebrates, Cip/Kip CIUs also appear to be dispensable for cell cycle exit (de Nooij et aI., 1996; Lane et aI., 1996; Hong et a1., 1998) . Therefore, while the number of CiplKip CKI homo logs has expanded over the course of evolution, it appears that, remarkably, their basic functional requirement has been conserved.
Cip/Kip proteins regulate the timing of cell cycle exit in the spinal cord
Although neuronal differentiation can proceed in the spinal cord in the absence of p57 or all three Cip/Kip CKls, excess numbers of neurons are generated. Using genetic lineage tracing, we provide direct evidence that interneurons targeted for differentiation re-enter the cell cycle abnonnally inp57 mutants, but ultimately exit to differentiate in the mantle zone. That the loss of a single factor, p57, can result in cell cycle re-entry indicates that a pool of nascent neurons still possess the inherent capacity to enter S-and M-phases even though they are in the process of exiting the cell cycle to begin differentiation, and thus should fonnally be regarded as "progenitors". The observation that the G I cyclin D I, as well as some well-characterized progenitor factors such as Pax6, are co-expressed with p57 in cells at the lateral margins of the VZ is consistent with this idea. The increase in the number of post-mitotic neurons at early neurogenic stages is therefore likely to result from a transient expansion of this neuronally restricted "progenitor" pool in mutants. Consistent with this, loss of p57 does not affect the generation of oligodendrocyte glial progenitors at later stages (Casaccia-Bonnefil, personal communication), indicating that it is specifically required in this restricted pool and not the common neuronal/glial pool that populates the VZ at these stages. p57 expression thus appears to define the transition between a distinct neural "progenitor" state, where G I cyclin activity predominates, and a post-proliferative GO state, where cell cycle promoting activities are downregulated and neuronal differentiation has begun. Interestingly, a similar function for regulating cell cycle exit for a subpopulation of neuronal stem cells residing in the sub-ventricular zone of the adult rodent brain has been assigned to p27 (Doetsch et a!., 2002). These observations suggest that Cip/Kip CKIs may play a similar regulatory role in controlling G I-GO transitions in both embryonic and adult neurogenesis In mammals.
Taken with published studies on the molecular control of neurogenesis, our studies support a model whereby cell cycle withdrawal is a multistep process. [n this view, the initial signal/ s that stimulate cell cycle exit likely occur prior to the final mitosis or early in G I phase, and the expression and function of several bHLH neurogenic factors make them likely candidates for playing a central role in this process. For example, Ngn2 can induce full-blown neuronal differentiation as well as precocious p57 expression when mis-expressed in chick neural progenitors (Fig. 7) , while over-expression of p57 does not induce this factor (data not shown) or neuronal differentiation. However, the direct activities of bHLH factors alone are not likely to be sufficient to provide the sharp tennination of cyclin D or E activity necessary for precise cell cycle exit in proliferating neural progenitors at early neurogenic stages, requiring a second inhibitory mechanism that links directly to the cell cycle machinery-a role played by p57.
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